MKI67 and breast carcinoma: Breast cancer exhibits significant heterogeneity, leading to variations in its biological behavior and clinical prognosis.[15] Prognostic factors, such as estrogen receptor or progesterone receptor status, HER2 status, Ki-67, tumor size, and metastasis to axillary lymph nodes play a crucial role in breast cancer.